UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (187) 187
animals (181) 181
life sciences & biomedicine (172) 172
metalloporphyrins - pharmacokinetics (123) 123
humans (110) 110
male (85) 85
mice (83) 83
metalloporphyrins - pharmacology (79) 79
rats (60) 60
female (56) 56
metalloporphyrins - therapeutic use (56) 56
tissue distribution (52) 52
biochemistry & molecular biology (44) 44
metalloporphyrins - chemistry (43) 43
metalloporphyrins - administration & dosage (37) 37
pharmacology & pharmacy (37) 37
metalloporphyrins (36) 36
oncology (32) 32
photochemotherapy (31) 31
cell line, tumor (30) 30
radiology, nuclear medicine & medical imaging (30) 30
dose-response relationship, drug (29) 29
photosensitizing agents - pharmacokinetics (28) 28
cancer (27) 27
biophysics (26) 26
porphyrins (25) 25
antineoplastic agents - pharmacokinetics (24) 24
physical sciences (22) 22
chemistry (21) 21
heme oxygenase - antagonists & inhibitors (21) 21
oxidative stress (20) 20
antioxidants - pharmacology (19) 19
mice, inbred c57bl (19) 19
disease models, animal (18) 18
motexafin gadolinium (18) 18
photodynamic therapy (18) 18
abridged index medicus (17) 17
antineoplastic agents - therapeutic use (17) 17
gadolinium (17) 17
magnetic resonance imaging (17) 17
metalloporphyrins - metabolism (17) 17
neoplasm transplantation (17) 17
photosensitizing agents - therapeutic use (17) 17
contrast media - pharmacokinetics (16) 16
metalloporphyrin (16) 16
mice, inbred balb c (16) 16
neoplasms - drug therapy (16) 16
protoporphyrins - pharmacology (16) 16
analysis (15) 15
heme oxygenase - metabolism (15) 15
magnetic resonance imaging - methods (15) 15
porphyrin (15) 15
porphyrins - pharmacokinetics (15) 15
rats, wistar (15) 15
metalloporphyrins - toxicity (14) 14
oxidation-reduction (14) 14
photochemotherapy - methods (14) 14
radiation-sensitizing agents - pharmacokinetics (14) 14
research (14) 14
time factors (14) 14
antineoplastic agents - pharmacology (13) 13
care and treatment (13) 13
liver - metabolism (13) 13
middle aged (13) 13
photosensitizing agents - pharmacology (13) 13
rats, sprague-dawley (13) 13
superoxide dismutase - metabolism (13) 13
tumors (13) 13
health aspects (12) 12
heme - metabolism (12) 12
metalloporphyrins - chemical synthesis (12) 12
oxidative stress - drug effects (12) 12
protoporphyrins - pharmacokinetics (12) 12
radiation-sensitizing agents - therapeutic use (12) 12
apoptosis (11) 11
brain neoplasms - radiotherapy (11) 11
cell survival - drug effects (11) 11
cells, cultured (11) 11
liposomes (11) 11
metalloporphyrins - adverse effects (11) 11
molecular structure (11) 11
pharmacokinetics (11) 11
toxicology (11) 11
tumor cells, cultured (11) 11
adult (10) 10
antineoplastic agents - administration & dosage (10) 10
antioxidants (10) 10
combined modality therapy (10) 10
infant, newborn (10) 10
metalloporphyrins - blood (10) 10
neurosciences & neurology (10) 10
physiology (10) 10
rabbits (10) 10
radiotherapy (10) 10
rats, inbred f344 (10) 10
aged (9) 9
biology (9) 9
brain neoplasms - drug therapy (9) 9
cell biology (9) 9
cell line (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of controlled release, ISSN 0168-3659, 2011, Volume 155, Issue 3, pp. 367 - 375
Journal Article
Toxicology and applied pharmacology, ISSN 0041-008X, 07/2017, Volume 326, pp. 34 - 42
Reactive oxygen species are a well-defined therapeutic target for Parkinson's disease (PD) and pharmacological agents that catalytically scavenge reactive... 
Antioxidants | Oxidative stress | Dopamine | MPTP | Drug development | Pharmacokinetic analysis | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Antiparkinson Agents - pharmacology | Capillary Permeability | MPTP Poisoning - physiopathology | Half-Life | Motor Activity - drug effects | Biological Availability | Male | Metalloporphyrins - pharmacology | Brain - metabolism | Neuroprotective Agents - pharmacology | Neuroprotective Agents - pharmacokinetics | Metalloporphyrins - administration & dosage | Drug Design | Behavior, Animal - drug effects | Drug Evaluation, Preclinical | Neuroprotective Agents - administration & dosage | Dopamine - metabolism | Metalloporphyrins - pharmacokinetics | Disease Models, Animal | Biomarkers - metabolism | Administration, Oral | Brain - physiopathology | MPTP Poisoning - etiology | Mice, Inbred C57BL | Injections, Intraperitoneal | Antioxidants - pharmacology | MPTP Poisoning - prevention & control | Blood-Brain Barrier - metabolism | Antiparkinson Agents - pharmacokinetics | Brain - drug effects | Rotarod Performance Test | Animals | MPTP Poisoning - metabolism | Antioxidants - administration & dosage | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Antiparkinson Agents - administration & dosage | Oxidative Stress - drug effects | Antioxidants - pharmacokinetics | Physiological aspects | Permeability | Health aspects | Enzymes | Parkinson's disease | Neurons | Superoxide | Index Medicus | CATALASE | HALF-LIFE | OXIDATION | SUPEROXIDE DISMUTASE | ANTIOXIDANTS | PERMEABILITY | BIOLOGICAL AVAILABILITY | 60 APPLIED LIFE SCIENCES | THERAPEUTIC DOSES | DISULFIDES | NERVOUS SYSTEM DISEASES | METABOLISM | GLUTATHIONE | MANGANESE | DOPAMINE | MICE | BRAIN | BLOOD | Pharmacokinetic Analysis | antioxidants
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2015, Volume 93, Issue 4, pp. 892 - 900
Purpose To test the effects of a novel Mn porphyrin oxidative stress modifier, Mn(III) meso- tetrakis( N -n-butoxyethylpyridinium-2-yl)porphyrin (MnBuOE), for... 
Radiology | Hematology, Oncology and Palliative Medicine | Oncology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Organs at Risk - radiation effects | Salivary Glands - pathology | Radiation-Protective Agents - pharmacokinetics | Radiation-Sensitizing Agents - pharmacokinetics | Organs at Risk - pathology | Radiation-Sensitizing Agents - therapeutic use | Mouth Mucosa - radiation effects | Metalloporphyrins - therapeutic use | Radiation Injuries, Experimental - prevention & control | Salivary Glands - radiation effects | Fibrosis - prevention & control | Metalloporphyrins - pharmacokinetics | Drug Evaluation, Preclinical - methods | Mice, Inbred C57BL | Radiation Dosage | Random Allocation | Stomatitis - etiology | Xerostomia - prevention & control | Head and Neck Neoplasms - radiotherapy | Animals | Mice, Nude | Fibrosis - etiology | Radiation-Protective Agents - therapeutic use | Stomatitis - prevention & control | Mice | Xerostomia - etiology | Dose-Response Relationship, Radiation | Sects | Superoxide | Health aspects | Cancer | Biomedical engineering | Porphyrins | Index Medicus | NEOPLASMS | BIOMEDICAL RADIOGRAPHY | SALIVARY GLANDS | RADIOLOGY AND NUCLEAR MEDICINE | PLANT TISSUES | ANIMAL TISSUES | RADIATION DOSES | RADIOTHERAPY | RADIATION INJURIES | MUCOUS MEMBRANES
Journal Article
PloS one, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, pp. e0134779 - e0134779
Journal Article